Douglas Chung, MS, is currently a Senior Director at Certara, specifically focused on quantitative systems pharmacology. He earned his BSc and MSc from the University of California, Los Angeles in biomedical engineering. He has over ten years of experience in modeling and simulation in drug discovery and development having worked with leading scientific and computational experts in several disease areas including autoimmune, neurodegenerative, immuno-oncology, and rare diseases. He has published original research and presented it at national pharmacology meetings.